drugset / Trial / NCT00603785

Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis

NCT00603785

RandomizedParallel-groupDouble-blindTreatment

Summary

We propose to study the effects of Xolair on patients with chronic sinusitis with or without nasal polyps. Because of the similarities between the inflammatory processes found in asthmas and rhinitis to those found in chronic sinusitis, we hypothesize that sinusitis should respond to Xolair, just as asthma.

Timeline

Start
2008-01
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Omalizumab Monoclonal antibody